Cy5.5 NHS Ester (Non-Sulfonated): Pushing the Boundaries of Near-Infrared Fluorescent Labeling

Introduction & Principle: Why Cy5.5 NHS Ester (Non-Sulfonated) Stands Apart

In the era of next-generation in vivo fluorescence imaging and molecular diagnostics, robust reagents that enable precise, deep-tissue, and low-background detection are critical. Cy5.5 NHS ester (non-sulfonated) emerges as a top-tier near-infrared fluorescent dye for biomolecule labeling, purpose-built for covalent conjugation to primary amines on peptides, proteins, and oligonucleotides. With an excitation maximum at ~684 nm and emission at ~710 nm, Cy5.5 provides superior tissue penetration and minimal autofluorescence, outclassing visible-range fluorophores for demanding applications such as optical imaging of tumors and real-time in vivo tumor imaging.

Unlike sulfonated analogs, the non-sulfonated Cy5.5 NHS ester is highly soluble in organic solvents like DMSO (≥35.82 mg/mL), enabling efficient biomolecule modification in diverse experimental settings. Its high extinction coefficient (209,000 M⁻¹cm⁻¹) and moderate quantum yield (0.2) ensure bright, reproducible labeling, even at low probe concentrations. Notably, the product is stable as a solid for up to 24 months at -20°C and should be freshly dissolved prior to use for optimal performance.

Step-by-Step Workflow: Optimized Protocols for Protein, Peptide, and Oligonucleotide Labeling

1. Preparing the Dye and Biomolecule

• Storage and Handling: Store Cy5.5 NHS ester (non-sulfonated) at -20°C in a dark, desiccated environment. Minimize light exposure during handling to prevent photobleaching.
• Solubilization: Dissolve the required amount of dye in anhydrous DMSO or DMF to a concentration of 5–10 mg/mL. The dye is not stable in solution; prepare immediately before conjugation.
• Buffer Preparation: Prepare the target biomolecule in a suitable buffer (e.g., 50 mM sodium bicarbonate, pH 8.3) free of primary amines and reducing agents. Tris and glycine buffers should be avoided as they compete for NHS ester reactivity.

2. Conjugation Reaction

1. Mixing Components: Add the Cy5.5 NHS ester solution dropwise to the biomolecule solution while gently vortexing. Use a typical molar ratio of dye:protein between 3:1 and 10:1 for optimal labeling efficiency.
2. Reaction Conditions: Incubate the reaction mixture for 1–2 hours at room temperature, protected from light.

3. Purification

• Remove excess dye by gel filtration (Sephadex G-25), dialysis, or spin columns. Validate removal by monitoring free dye absorbance at 684 nm.
• Quantify conjugation efficiency via absorbance at 684 nm (Cy5.5) and 280 nm (protein), correcting for dye contribution at 280 nm.

4. Validation and Storage

• Validate the labeled biomolecule via SDS-PAGE fluorescence imaging or spectrophotometry.
• Store conjugates at 4°C (short-term) or -20°C (long-term), protected from light.

For detailed workflow enhancements and troubleshooting in cell-based assays, refer to this scenario-driven guide, which complements the above protocol with best practices for maximizing sensitivity and reproducibility in protein and peptide labeling.

Advanced Applications: Comparative Advantages in Translational Research

1. In Vivo Tumor Imaging and Deep Tissue Applications

Cy5.5 NHS ester (non-sulfonated) is a premier tumor imaging agent for preclinical studies. Its near-infrared window emission allows real-time visualization of subcutaneous tumors in xenograft mouse models, with signal peaking at 30 minutes post-administration and persisting up to 24 hours. This facilitates high-contrast optical imaging of subcutaneous tumors and quantification of tumor uptake kinetics with minimal background interference.

The dye's performance is highlighted in Next-Generation Tumor Imaging and Microbiome Modulation, which explores its integration with microbiome-targeted strategies for enhanced metastasis detection, exemplifying the dye’s ability to support precision oncology workflows. In another mechanistic analysis, Cy5.5 NHS ester (non-sulfonated) is positioned as a cornerstone for both deep-tissue diagnostics and translational innovation at the intersection of oncology, immunology, and microbiome science.

2. Molecular Neuroscience and Neuromodulation

Pioneering studies, such as Li et al. (2025), have demonstrated the importance of advanced imaging probes in the development and monitoring of novel neuromodulation therapies. The robust performance of Cy5.5 NHS ester for in vivo fluorescence imaging can be leveraged to track nanoparticle localization, monitor delivery to neural tissues, and validate the spatial precision of piezoelectric-based interventions. Its low background and high specificity are especially advantageous for non-invasive studies where signal-to-noise is paramount.

3. Expanded Molecular Biology Toolset

Beyond protein and peptide labeling, Cy5.5 NHS ester (non-sulfonated) is a versatile oligonucleotide labeling reagent for nucleic acid tracking, hybridization assays, and gene delivery validation. Its compatibility with plasmid DNA enables multi-modal tracking in both cell culture and animal models, expanding its utility across genomics and synthetic biology.

For strategic guidance on integrating amino group labeling reagents into translational workflows, see Translating Mechanistic Insight to Action, which extends the current discussion with focus on emerging frontiers in diagnostic and therapeutic imaging.

Troubleshooting and Optimization: Maximizing Labeling Efficiency and Signal Quality

Common Pitfalls and Solutions

• Low Conjugation Efficiency: Ensure biomolecule buffer lacks competing amines (avoid Tris/glycine). Increase dye:biomolecule ratio or extend reaction time if needed.
• Precipitation During Labeling: Dissolve dye in anhydrous DMSO/DMF and add slowly to aqueous buffer. If precipitation persists, increase organic co-solvent up to 10% (v/v) or lower protein concentration.
• High Background Signal: Incomplete removal of free dye can elevate background. Use multiple rounds of gel filtration or dialysis. Check for free dye absorbance at 684 nm in flow-through.
• Photobleaching: Protect all solutions and conjugates from light throughout handling and storage.
• Batch Variability: Use freshly prepared dye solutions, and standardize reaction conditions. Validate each batch by measuring extinction coefficient and quantum yield.

Performance Metrics

• Extinction Coefficient: 209,000 M⁻¹cm⁻¹ (enables detection of sub-nanomolar targets).
• Quantum Yield: 0.2 (ensures bright, quantifiable labeling with minimal probe consumption).
• Signal Persistence: Tumor signals detectable up to 24 hours post-injection in vivo.

For a comprehensive troubleshooting framework and real-world troubleshooting scenarios, the article Empowering Cell Assays with Cy5.5 NHS Ester (Non-Sulfonated) offers actionable insights to overcome persistent challenges in protein and peptide conjugation workflows.

Future Outlook: Integrating Cy5.5 NHS Ester into Next-Generation Biomedical Research

As the scientific community advances towards more sophisticated in vivo tumor imaging dyes and real-time biosensors, Cy5.5 NHS ester (non-sulfonated) is poised to remain at the forefront. Its unique combination of deep tissue penetration, high signal-to-noise, and flexible bioconjugation chemistry ensures compatibility with emerging technologies—including multiplexed imaging, theranostics, and wireless neuromodulation platforms.

Innovative research, such as the integration of fluorescent dyes for protein conjugation in ultrasound-triggered piezo-nanoplatforms (see Ultrasound-Triggered Biomimetic Piezo-Nanoplatforms), highlights the expanding role of near-infrared probes in both experimental neuroscience and precision therapy. As multiplexed and multi-modal imaging become standard, the spectral properties and robust labeling efficiency of Cy5.5 NHS ester will be increasingly indispensable.

Conclusion

Whether you are delineating subcutaneous tumors, validating nanocarrier localization in neuromodulation studies, or optimizing workflows in molecular biology, Cy5.5 NHS ester (non-sulfonated) from APExBIO offers a proven, versatile, and data-driven solution. By integrating best-in-class photophysical performance with workflow compatibility and robust in vivo credentials, Cy5.5 NHS ester stands as a cornerstone for next-generation biomedical research.